Overview Financials News + Filings Key Docs Ownership Insiders
|
Talaris Therapeutics, Inc.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | 0.0% | 0.0% | 0.0% | |
ROIC (including intangibles) | 0.0% | 0.0% | 0.0% | -700.9% |
ROE | 0.0% | 0.0% | 0.0% | -46.4% |
ROA | 0.0% | 0.0% | 0.0% | -43.8% |
|
Cash Conversion Cycle |
Days sales outstanding | | | | 0.0 |
Days payables outstanding | | | | 9.1 |
Cash conversion cycle | | | | -9.1 |
|